港股異動丨港交所(0388.HK)逆勢漲超3% 大摩料中概股迴歸可令港交所收入倍增
格隆匯5月25日丨港交所(0388.HK)逆勢漲超3%,報265.6港元,總市值3367億港元。據文匯報,港交所正考慮縮短新股上市的招股結算週期,希望由5天減至1天,以增強市場競爭力。摩根士丹利發表報告,料港交所將受惠中概股迴歸上市及粵港澳大灣區金融發展。該行指,目前大多數的大型中概股美國預託證券(ADR)都符合在港上市的資格,不過預計只會選擇一小部分股票在港上市。大摩認為,如果合格的ADR都將在港交所上市,可令港交所收入翻倍。當中,日均成交額可增加約400億元,並推動衍生工具的收入貢獻,循環收取掛牌費。該行把港交所目標價升14.8%至310港元,維持“增持”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.